Enzo Biochem, Inc.
ENZB · OTC
4/30/2025 | 1/31/2025 | 10/31/2024 | 7/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,790 | -$1,535 | -$3,376 | -$13,381 |
| Dep. & Amort. | $318 | $318 | $319 | $398 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | -$39 | $178 | $171 | $259 |
| Change in WC | -$186 | $6,378 | -$6,378 | $8,439 |
| Other Non-Cash | -$523 | -$7,365 | $274 | $3,200 |
| Operating Cash Flow | -$3,220 | -$2,026 | -$8,990 | -$1,085 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$386 | -$70 | -$448 | -$123 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $5,000 | $0 |
| Investing Cash Flow | -$386 | -$70 | $4,552 | -$123 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$42 | $0 | -$37 | -$3,609 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$5,324 | -$5,324 | $0 | $0 |
| Other Fin. Act. | $5,324 | $0 | -$163 | $0 |
| Financing Cash Flow | -$42 | -$5,324 | -$200 | -$3,609 |
| Forex Effect | $44 | -$18 | $2 | $32 |
| Net Chg. in Cash | -$3,604 | -$7,438 | -$4,636 | -$4,785 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $40,297 | $47,735 | $52,371 | $57,156 |
| End Cash | $36,693 | $40,297 | $47,735 | $52,371 |
| Free Cash Flow | -$3,606 | -$2,096 | -$9,438 | -$1,208 |